|
Last Updated: Nov 18, 2006 - 12:32:53 PM |
Latest Research
:
Musculoskeletal
:
Muscular Dystrophies
Trichostatin A (TSA) Can Counteract Muscular Dystrophy in Mice
Scientists at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other institutions have demonstrated for the first time that a single drug can rebuild damaged muscle in two strains of mice that develop diseases comparable to two human forms of muscular dystrophy. This advance, which is reported online in Nature Medicine, is the latest from a research collaboration that began several years ago by the teams of Vittorio Sartorelli, M.D., at NIAMS and Pier Lorenzo Puri, M.D., Ph.D., now at Dulbecco Telethon Institute (DTI) in Rome, Italy and The Burnham Institute in La Jolla, Calif.
Oct 5, 2006 - 1:08:00 AM
Latest Research
:
Musculoskeletal
Fibromyalgia often misdiagnosed in pregnant women
Pregnant women with fibromyalgia (FM) experience significant pain, fatigue and psychological stress, symptoms that are often misdiagnosed or undertreated as a normal part of pregnancy, according to a pilot study by Karen M. Schaefer, D.N.Sc., R.N., assistant professor of nursing at Temple University's College of Health Professions.
Jul 6, 2006 - 2:58:00 AM
Latest Research
:
Musculoskeletal
:
Muscular Dystrophies
Valproate effective in adult spinal muscular atrophy (SMA)
An epilepsy drug that has been on the market for decades can ease the symptoms of adult sufferers with a genetic disorder that seriously weakens muscles. Scientists at Washington University School of Medicine in St. Louis retrospectively reviewed results from off-label use of the drug valproate to treat seven adult spinal muscular atrophy (SMA) patients. Clinicians offered the drug to patients on the basis of research conducted elsewhere that showed the drug increased levels of a key protein in cell cultures.
Jun 24, 2006 - 3:00:00 AM
Latest Research
:
Musculoskeletal
Cherry Juice May Prevent Muscle Damage Pain
The familiar "no pain, no gain" phrase usually associated with exercise may be a thing of the past if results from a study on cherry juice published today in the online version of the British Journal of Sports Medicine prove true in future research.
Jun 23, 2006 - 12:03:00 AM
Latest Research
:
Musculoskeletal
Natural pine bark extract Pycnogenol relieves muscle cramp and pain in athletes and diabetics
A study published in this month's issue of Angiology shows that supplementation with the pine bark extract Pycnogenol� (pic-noj-en-all) improves blood flow to the muscles which speeds recovery after physical exercise. The study of 113 participants demonstrated that Pycnogenol significantly reduces muscular pain and cramps in athletes and healthy, normal individuals.
Jun 17, 2006 - 1:41:00 AM
Latest Research
:
Musculoskeletal
:
Muscular Dystrophies
Muscular dystrophy - early cardiac screening shows better outcomes
Cardiac disease, particularly dilated cardiomyopathy and heart failure, is the major cause of mortality in patients with muscular dystrophy.Intervention with ACE inhibitor or beta blocker therapy improves heart size and function.
Oct 30, 2005 - 3:02:00 PM
Latest Research
:
Musculoskeletal
:
Pagets Disease
Single Infusion of Zoledronic Acid More Effective in Paget�s Disease
A head-to-head study published in The New England Journal of Medicine reports that a single infusion of the investigational bisphosphonate, zoledronic acid 5 mg solution, offers superior efficacy, longer period of remission, and faster onset of action compared to the oral bisphosphonate risedronate (Actonel�) in patients with Paget�s disease.
Sep 8, 2005 - 1:08:00 AM
Latest Research
:
Musculoskeletal
:
Pagets Disease
Studies confirm new treatments for Paget's disease
Two studies led by researchers at The University of Auckland's Faculty of Medical and Health Sciences have pioneered new, more effective treatment for two forms of Paget's disease - a chronic and often painful bone disease.
Sep 5, 2005 - 11:56:00 PM
Latest Research
:
Musculoskeletal
:
Muscular Dystrophies
Gene therapy success for congenital muscular dystrophy (CMD)
Researchers from the University of Pittsburgh report the first study to achieve success with gene therapy for the treatment of congenital muscular dystrophy (CMD) in mice, demonstrating that the formidable scientific challenges that have cast doubt on gene therapy ever being feasible for children with muscular dystrophy can be overcome. Moreover, their results, published in this week's online edition of the Proceedings of the National Academy of Sciences (PNAS), indicate that a single treatment can have expansive reach to muscles throughout the body and significantly increase survival.
Aug 16, 2005 - 7:46:00 PM
Latest Research
:
Musculoskeletal
:
Falls
Avoid Falls!
Whether it is caused by a wet floor, slippery throw rug, loose cord or objects in the wrong spot, falls in the home happen. The truth is, falls are not only the most common cause of injury among American adults age 65 and over, but are also the leading cause of death in the home, according to the National Safety Council.
Aug 12, 2005 - 12:26:00 AM
Latest Research
:
Musculoskeletal
:
Falls
Genes may ultimately dictate seniors' mobility
Genes can keep elderly people from benefiting equally from exercise, no matter how much effort they expend, according to research findings published in today's (Aug. 10) Journal of the American Medical Association.
Aug 10, 2005 - 12:28:00 AM
Latest Research
:
Musculoskeletal
:
Falls
Frequent falls?....Try Tai Chi
Falls are a major problem in the elderly and form a substantial proportion of the admissions in hospitals. Older people who took part in a structured programme of Tai Chi found that their balance and physical strength improved, reducing the risk of falls, according to a paper in the latest Journal of Advanced Nursing.
Jun 28, 2005 - 12:24:00 AM
Latest Research
:
Musculoskeletal
:
Pagets Disease
European Commission Approves Zoledronic acid for the Treatment of Paget's Disease of Bone
Novartis Pharma AG announced today that Aclasta� (zoledronic acid 5mg solution for infusion) has been granted Marketing Authorization by the European Commission for the treatment of Paget's disease of the bone in all 25 European member states, as well as Norway and Iceland. This represents the first approval for Aclasta.
Apr 24, 2005 - 8:13:00 AM
<< prev
next >>
|
